Written by The Vascular Graft Market is developing alongside advances in cardiovascular surgery, endovascular treatment, and vascular access management. Rising rates of vascular disease and an aging population are contributing to demand for grafts used in aneurysm repair, peripheral vascular reconstruction, and dialysis access. The market is forecast to grow at a 7.4% CAGR between 2026 and 2035.
Material innovation is an important area of development. ePTFE held the largest material share at 43.4% in 2025, while biosynthetic materials are projected to grow at an 8.5% CAGR. These materials are being explored for their potential to improve tissue integration and address limitations associated with conventional synthetic grafts. Bioresorbable and tissue-engineered approaches are also creating new possibilities for personalized vascular reconstruction.
Endovascular stent grafts represented 49.8% of product revenue in 2025, reflecting continued demand for procedures that can reduce recovery time and hospital stays. Meanwhile, 3D-printed bioresorbable grafts are projected to grow at an 8.1% CAGR. In applications, aortic and peripheral aneurysm repair holds the largest share, while hemodialysis access is the fastest-growing application.
Future market opportunities include tissue-engineered conduits, sensor-enabled post-implant monitoring, patient-specific 3D-printed grafts, and expanded vascular treatment capacity in emerging economies. North America remains the largest market, whereas Asia-Pacific offers significant growth potential as healthcare infrastructure expands. These developments are expected to encourage further investment in advanced vascular graft technologies through 2035.
Access detailed findings to navigate market complexities:
Cardiac Pacemaker Market Volume
Chronic Obstructive Pulmonary Disease Copd Market Forecast
Chronic Obstructive Pulmonary Disease Copd Market Outlook
Chronic Obstructive Pulmonary Disease Copd Market Analysis
Chronic Obstructive Pulmonary Disease Copd Market Distribution